Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Portfolio Pulse from Ryan Gustafson
Hims & Hers Health, Inc. (NYSE:HIMS) reported mixed Q3 results with earnings missing analyst estimates but revenue beating expectations. The company also announced a $50 million share repurchase program and raised its full-year 2023 revenue guidance. Shares were up 6.54% in after-hours trading.
November 06, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health reported mixed Q3 results but raised its FY23 revenue guidance and announced a $50 million share buyback. This news led to a 6.54% increase in the company's share price in after-hours trading.
The company's mixed Q3 results may have initially caused some uncertainty among investors. However, the announcement of a $50 million share buyback and the raising of FY23 revenue guidance are positive signals that could boost investor confidence, leading to the increase in the company's share price in after-hours trading.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100